Data / Investment advisers / New York / Royalty Pharma Sub-Manager, LLC
Royalty Pharma Sub-Manager, LLC, New York, NY: $19.6 billion AUM, SEC registered investment adviser
Royalty Pharma Sub-Manager, LLC is an SEC registered investment adviser with its main office in New York, New York and reports $19.6 billion in regulatory assets under management in its Form ADV filed May 4, 2026. Its clients include pooled investment vehicles. It is paid through a percentage of assets under management, fixed fees and performance based fees. It advises 2 private funds.
SpecStream is the live web data engine for teams and agents. It reads the SEC's Form ADV files every month, and this page is that reading, keyed on the CRD number. Ask for the advisers you track by state, city, size, client type or private funds, and new registrations and filings arrive in your sheet, CRM, Slack or agent as the SEC publishes them.
- Registration
- SEC registered investment adviser
- CRD number
- 335070
- SEC file number
- 801-132133
- SEC status
- Approved, effective March 7, 2025
- Main office
- 110 East 59th Street, New York, NY 10022
- Phone
- (212) 883-0200
- Regulatory AUM
- $19,638,739,455 in the Form ADV filed May 4, 2026
- Discretionary AUM
- $19,638,739,455
- Accounts
- 7
- Employees
- 91, of which 48 give investment advice
- Form of organization
- Limited Liability Company
- Paid through
- a percentage of assets under management, fixed fees, performance based fees, other fees
- Private funds
- 2: 2 private equity funds
- Gross assets of private funds
- $1,446,167,077
- Form ADV Item 11 disclosures
- None reported
- Latest Form ADV filing
- May 4, 2026
- SEC record
- Investment Adviser Public Disclosure
Clients
Client types the adviser reports in Form ADV item 5.D, with the AUM it attributes to each.
| Client type | Clients | AUM |
|---|---|---|
| Pooled investment vehicles | 7 | $19.64 billion |
AUM in the SEC's monthly files
Each change in the AUM the adviser reported across the monthly SEC files held here, with the first file that shows the new value.
| First in the file of | AUM | Form ADV filed |
|---|---|---|
| April 1, 2026 | $19.64 billion | March 31, 2026 |
| December 1, 2025 | $17.63 billion | June 15, 2025 |
Other advisers in New York
| Adviser | City | AUM | Private funds | Source |
|---|---|---|---|---|
| Mutual of America Capital Management LLC | New York | $20.13 billion | Not listed | adviserinfo.sec.gov |
| Blackstone Alternative Solutions L.L.C. | New York | $20.08 billion | 40 | adviserinfo.sec.gov |
| BXMT Advisors L.L.C. | New York | $20.00 billion | 1 | adviserinfo.sec.gov |
| Summit Trail Advisors, LLC | New York | $19.94 billion | 16 | adviserinfo.sec.gov |
| Record Currency Management Inc | New York | $19.66 billion | Not listed | adviserinfo.sec.gov |
| Park Avenue Securities LLC | New York | $19.58 billion | Not listed | adviserinfo.sec.gov |
| Egerton Capital (US), LP | New York | $19.53 billion | Not listed | adviserinfo.sec.gov |
| PDT Partners, LLC | New York | $19.18 billion | 4 | adviserinfo.sec.gov |
Also on SpecStream
- Investment advisers in New York, NY
- Investment advisers in New York
- Advisers with $10 billion to $100 billion in AUM
- Advisers serving pooled investment vehicles
- Advisers that manage private funds
- Royalty Pharma Sub-Manager, LLC on the SEC's adviser search
Updated November 7, 2026. Read from the SEC's Form ADV data files for investment advisers. Public data published by the US Securities and Exchange Commission (US government work). Advisers report these values themselves in Form ADV, and neither the SEC nor the states approve or guarantee them. AUM is regulatory assets under management as the adviser reported it in Form ADV item 5.F, which can differ from the AUM a firm quotes elsewhere. Exempt reporting advisers do not report AUM. Office address, phone and website are the adviser's main office as filed; a firm that files its main office as a private residence shows no street address or phone. An Item 11 disclosure is a reported event, not a finding about the firm today. Details for each firm are on the SEC's Investment Adviser Public Disclosure site. This page uses SEC data and is not endorsed or certified by the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.